Contact with and (suspected) exposure to lead. 2016 2017 2018 2019 2020 2021 Billable/Specific Code. Z77.011 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z77.011 became effective on October 1, 2020.
R78.71 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM R78.71 became effective on October 1, 2021. This is the American ICD-10-CM version of R78.71 - other international versions of ICD-10 R78.71 may differ. A type 1 excludes note is a pure excludes.
Z13.88 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z13.88 became effective on October 1, 2021. This is the American ICD-10-CM version of Z13.88 - other international versions of ICD-10 Z13.88 may differ. A type 1 excludes note is a pure excludes.
DOM covers CPT code 83655 (lead testing) outside of the Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) or wellness benefit for all beneficiaries when billed with a QW modifier. The ICD-10 code for contact with and (suspected) exposure to lead is Z77. 011.
Z77.011ICD-10 Code for Contact with and (suspected) exposure to lead- Z77. 011- Codify by AAPC.
9.
Encounter DescriptionCodes1Venous blood collectionCPT 36415Capillary blood collectionCPT 36416Lead testCPT 83655Abnormal lead level in bloodICD-10 R78.716 more rows
30 µg/m3The required (OSHA) Permissible Exposure Limit (PEL) action level for lead in general industry and the construction industry is a Time Weighted Average of 30 µg/m3 over 8-hours.
The lead standards establish a permissible exposure limit (PEL) of 50 μg/m3 of lead over an eight-hour time-weighted-average for all employees covered.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon.
For example, Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is the correct code to use when you are ordering a routine mammogram for a patient. However, coders are coming across many routine mammogram orders that use Z12. 39 (Encounter for other screening for malignant neoplasm of breast).
Other specified counselingICD-10 code Z71. 89 for Other specified counseling is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Description: Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count.
36415—Collection of venous blood by venipuncture. Our claims editing system may deny as unbundled when billed with any E&M, lab or other procedure codes. 36416—Collection of capillary blood specimen.
CPT Code 83655. (For CLIA-certified laboratories) Pathology and Laboratory Lead Chemistry.
Abnormal finding of blood chemistry, unspecified The 2022 edition of ICD-10-CM R79. 9 became effective on October 1, 2021.
In simple meaning Excludes 1, note codes cannot be coded together with that ICD 10 code. Now, coming to Excludes 2 it is totally opposite to Excludes 1. The codes in Excludes 2 can be used together at same time.
Format and Use of Alphabetic Index The first lead term is "Abdomen." Since there are more than three modifying terms, Abdomen is in bold type. The "NOS" term is always listed first under a heading in the index (rather than in alphabetic order under N).
ICD-10 code D50. 9 for Iron deficiency anemia, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
The Centers for Disease Control and Prevention defines lead poisoning as a blood lead level of 10 mg/dL.
When lead-based paint peels and chips off of older walls, it can be inhaled and cause permanent damage to a young child's nervous system. Recurrent exposure to even small amounts of lead may result in lead poisoning since lead can accumulate in the body. Neurobehavioral abnormalities of mild lead poisoning may manifest as lowered IQ scores, decreased attention span, impaired hearing, speech and other developmental delays; however, most children of pre-school age with mild lead poisoning are asymptomatic. The probability of developing encephalopathy, the most serious complication of lead poisoning, increases as the exposure to lead and blood level of lead rises. Encephalopathy may be preceded by abdominal pain, headaches, vomiting, and constipation. The Centers for Disease Control and Prevention defines lead poisoning as a blood lead level of 10 mg/dL. As sustained blood levels rise above 10 to 15 mg/dL, young children under age 6 years are at progressively increasing risk not only for future neurobehavioral and cognitive problems, but also for development of recurrent symptomatic episodes of physical manifestations of lead poisoning.
Note: Routine blood lead testing for average-risk pregnant women without risk factors is not considered medically necessary. Aetna considers measurement of lead in bone, hair, teeth, or urine experimental and investigational because the effectiveness of these approaches has not been established.
In addition, Aetna considers lead screening a medically necessary preventive health care service for children according to guidelines from the Centers for Disease Control and Prevention (CDC), the U.S. Preventive Services Task Force (USPSTF), the American Academy of Pediatrics (AAP), and the American Academy of Neurology (AAN).
Per the American College of Obstetricians and Gynecologists (ACOG, 2012), routine blood lead testing of all pregnant women is not recommended; however, risk assessment of lead exposure should take place at the earliest contact with pregnant or lactating women.
The blood lead level is a good indicator of exposure that has occurred within the previous few weeks . In interpreting the results, it is important to use levels appropriate to adult toxicity, rather than children's (which sometimes are the ranges of concern reported by the testing laboratories)".
The optimal frequency of screening for lead exposure in children, or for repeated testing of children previously found to have elevated blood lead levels, is unknown and is left to clinical discretion.